Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells

Journal of Molecular and Cellular Cardiology
De-Jian JiangYuan-Jian Li

Abstract

Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), is emerging as a key contributor for endothelial dysfunction and its effects on endothelium are not yet completely defined. The aim of this study was to investigate ADMA-induced apoptosis and its mechanisms in human umbilical vein endothelial cells (HUVECs). Apoptosis was evaluated by in situ terminal uridine nick end labeling (TUNEL) assay and DNA fragmentation analysis. Caspase-3 activity was measured using a colorimetric protease assay kit. Activations of mitogen-activated protein kinases (MAPKs) were characterized by Western blot and immunofluorescence. Intracellular oxidant production was measured using H(2)DCF-DA, an oxidant-sensitive fluorescent indicator. ADMA (3-30 microM) induced apoptosis of HUVECs in a dose- and time-dependent manner. Caspase-3 was activated during apoptosis and its specific inhibitor DEVD-CHO significantly attenuated ADMA-induced apoptosis. Phosphorylation of p38 MAPK was induced by ADMA, and p38 MAPK specific inhibitor SB203580 concentration-dependently prevented ADMA-induced caspase-3 activation and cell apoptosis. ADMA increased intracellular oxidant production, which was significantly suppressed by intra...Continue Reading

Citations

Aug 30, 2013·Canadian Journal of Physiology and Pharmacology·Xue HanWen-Hu Liu
Jun 3, 2011·World Journal of Gastroenterology : WJG·Zhe ZhangChang-Ping Hu
Feb 28, 2013·International Journal of Molecular Sciences·Shufen ChenHans Worthmann
Aug 4, 2009·American Journal of Respiratory Cell and Molecular Biology·Tanveer AhmadAnurag Agrawal
Jun 19, 2010·American Journal of Respiratory Cell and Molecular Biology·Tanveer AhmadAnurag Agrawal
Nov 26, 2009·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Su-Jie JiaYuan-Jian Li
Dec 11, 2007·Journal of Thrombosis and Thrombolysis·Giulio ColuzziFelicita Andreotti
Jan 22, 2009·European Journal of Clinical Pharmacology·Mei-Fang ChenXiu-Mei Xie
Nov 26, 2009·Naunyn-Schmiedeberg's Archives of Pharmacology·Chen-Jing WangYuan-Jian Li
Apr 4, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jinghui LuoAkira Hishida
Jun 17, 2011·Science Translational Medicine·Soni Savai PullamsettiRalph Theo Schermuly
Aug 20, 2015·International Journal of Molecular Sciences·Qiusheng LanZhonghua Chu
Jun 21, 2011·The Journal of Nutritional Biochemistry·Carlos Enrique Guerrero-BeltránPál Pacher
Apr 3, 2007·Biochemical and Biophysical Research Communications·Qiong YuanYuan-Jian Li
May 30, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Junfang DengShusen Zheng
Jan 19, 2012·Biotechnology and Bioengineering·Suresh SelvarasuDong-Yup Lee
Nov 7, 2008·Journal of Zhejiang University. Science. B·Yun ZhangZuo-Bing Chen
May 13, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Hua LiChun-Hua Hang
Aug 19, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Shiuh-Inn LiuChung-Ren Jan
Mar 31, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Ben Caplin, James Leiper
May 30, 2015·Journal of the American Heart Association·Peter WilleitRajiv Chowdhury
Sep 26, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Lorna R FiedlerBeata Wojciak-Stothard
Jun 7, 2007·Journal of Vascular Research·Mei-Fang ChenYuan-Jian Li
Jul 5, 2007·Cancer Chemotherapy and Pharmacology·Deguang MuFaguang Jin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.